Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 136   

Articles published

ABT 55.56 +0.04 (0.07%)
price chart
Galena Biopharma (GALE) vs. Abbott Laboratories (ABT) Financial Review
Galena Biopharma (NASDAQ: GALE) and Abbott Laboratories (NYSE:ABT) are both pharmaceuticals - nec companies, but which is the superior stock?
Abbott's Inviting New Allure
To date, Abbott (NYSE:ABT) has had a gratifyingly successful 2017. Its stock has ... Abbott's other three divisions are benefiting from acquisitions, in the case of devices and diagnostics, and from regulatory adjustment, in the case of nutrition.
High-Level Earnings Momentum Keep Abbott Laboratories (ABT) a Buy
Currently, Abbott Laboratories (NYSE:ABT) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology.
Abbott Laboratories (ABT) versus Galena Biopharma (NASDAQ:GALE) Head-To-Head ...
Abbott Laboratories (NYSE: ABT) and Galena Biopharma (NASDAQ:GALE) are both medical companies, but which is the better business?
Dr. Reddy's Laboratories (NYSE:RDY) & Abbott Laboratories (ABT) Head ...  StockNewsTimes
Outlining the overall picture in today's market for – Abbott ...  The News Journal
Abbott Laboratories' (ABT) High-Level Sales Growth Make it a Buy
Abbott Laboratories (NYSE:ABT) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system.
How These Rivals Could Take A Chunk Of Medtronic's Heart-Unit Sales
Autoplay: On | OffIn September, Abbott caught up to Medtronic and Boston, gaining approval for an implantable cardioverter defibrillator, or ICD, that allows a patient to undergo an MRI scan if needed.
Abbott Laboratories (ABT) a Buy on Healthy Sales Growth
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) is computed using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator.
Abbott Laboratories (ABT) a Buy on Solid Sales Growth
Currently, Abbott Laboratories (NYSE:ABT) has a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator.
See Which Of The Latest 13F Filers Holds Abbott Laboratories
At Holdings Channel , we have reviewed the latest batch of the 21 most recent 13F filings for the 09/30/2017 reporting period, and noticed that Abbott Laboratories (Symbol: ABT) was held by 14 of these funds. When hedge fund managers appear to be ...
Earnings Clues on Synergy Pharmaceuticals Inc. (SGYP), Abbott Laboratories ...  StockNewsJournal
Street Analysts View On Abbott Laboratories (ABT), Agios Pharmaceuticals ...  Post Analyst
Waltzing Stocks: Abbott Laboratories, (NYSE: ABT), Brinker International, Inc ...
The Healthcare stock (Abbott Laboratories) showed a change of 0.49 percent from opening and finally turned off its business at $55.56 by scoring 0.04 percent on Friday.